X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15001) 15001
Publication (888) 888
Book Review (155) 155
Magazine Article (63) 63
Book Chapter (22) 22
Conference Proceeding (20) 20
Book / eBook (17) 17
Dissertation (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11012) 11012
hypolipidemic agents - therapeutic use (8553) 8553
male (7621) 7621
animals (5014) 5014
female (4953) 4953
hypolipidemic agents - pharmacology (4405) 4405
index medicus (4222) 4222
middle aged (4003) 4003
rats (2810) 2810
aged (2802) 2802
adult (2686) 2686
risk factors (2544) 2544
hyperlipidemias - drug therapy (2474) 2474
pharmacology & pharmacy (2208) 2208
triglycerides - blood (2177) 2177
cholesterol (2110) 2110
lipids - blood (1943) 1943
hypolipidemic agents - administration & dosage (1925) 1925
cholesterol - blood (1920) 1920
cardiac & cardiovascular systems (1549) 1549
treatment outcome (1474) 1474
cholesterol, ldl - blood (1473) 1473
hypolipidemic agents - adverse effects (1466) 1466
mice (1369) 1369
atherosclerosis (1322) 1322
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1281) 1281
medicine, general & internal (1269) 1269
cholesterol, hdl - blood (1220) 1220
lipids (1204) 1204
cardiovascular diseases - prevention & control (1143) 1143
coronary-heart-disease (1067) 1067
dyslipidemias - drug therapy (1043) 1043
statins (997) 997
drug therapy, combination (994) 994
liver - metabolism (984) 984
liver - drug effects (975) 975
risk (936) 936
hyperlipidemias - blood (933) 933
hypercholesterolemia - drug therapy (890) 890
peripheral vascular disease (889) 889
prevention (858) 858
endocrinology & metabolism (848) 848
time factors (841) 841
clinical trials as topic (811) 811
antihypertensive agents - therapeutic use (790) 790
diabetes (780) 780
rats, wistar (760) 760
biochemistry & molecular biology (757) 757
triglycerides (749) 749
coronary disease - prevention & control (742) 742
fenofibrate - therapeutic use (730) 730
hyperlipidemia (722) 722
hypoglycemic agents - therapeutic use (720) 720
cardiovascular disease (711) 711
hypercholesterolemia (702) 702
dose-response relationship, drug (699) 699
cardiovascular-disease (696) 696
simvastatin (693) 693
chemistry, medicinal (686) 686
metabolism (679) 679
hypolipidemic agents - chemistry (677) 677
fenofibrate (670) 670
rats, sprague-dawley (668) 668
hyperlipidemias - complications (660) 660
hypolipidemic agents (658) 658
disease (657) 657
myocardial-infarction (651) 651
research (651) 651
diet (637) 637
care and treatment (622) 622
diabetes mellitus, type 2 - drug therapy (617) 617
dyslipidemia (615) 615
double-blind method (600) 600
therapy (597) 597
health aspects (585) 585
analysis (581) 581
biomarkers - blood (577) 577
mortality (576) 576
lipid metabolism (575) 575
cardiovascular diseases - etiology (567) 567
lipoproteins - blood (560) 560
fenofibrate - pharmacology (552) 552
lipoproteins (550) 550
drug therapy (549) 549
diabetes mellitus, type 2 - complications (548) 548
niacin - therapeutic use (547) 547
insulin resistance (523) 523
low density lipoproteins (521) 521
plant extracts - pharmacology (520) 520
practice guidelines as topic (519) 519
aged, 80 and over (518) 518
hypoglycemic agents - pharmacology (513) 513
risk assessment (510) 510
gemfibrozil (505) 505
blood glucose - metabolism (504) 504
anticholesteremic agents (498) 498
secondary prevention (497) 497
follow-up studies (495) 495
liver (495) 495
hypertension - drug therapy (492) 492
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12882) 12882
German (402) 402
French (332) 332
Russian (291) 291
Spanish (255) 255
Chinese (220) 220
Japanese (157) 157
Italian (146) 146
Polish (96) 96
Czech (70) 70
Hungarian (51) 51
Swedish (31) 31
Portuguese (28) 28
Danish (25) 25
Norwegian (23) 23
Dutch (20) 20
Finnish (15) 15
Romanian (11) 11
Ukrainian (10) 10
Lithuanian (7) 7
Slovak (7) 7
Bulgarian (5) 5
Croatian (4) 4
Korean (4) 4
Serbian (3) 3
Turkish (3) 3
Hebrew (2) 2
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
1975, ISBN 9780387073613, Volume 41. Bd., xiii, 488
Book
Journal Article
Food and Function, ISSN 2042-6496, 12/2014, Volume 6, Issue 1, pp. 296 - 33
Beneficial effects of green tea ( Camellia sinensis , Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major... 
SUPPLEMENTATION | OXIDATION | BODY-FAT | OBESITY | LIPID-METABOLISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | THEANINE | EPIGALLOCATECHIN GALLATE | CATECHINS | ANTIOXIDANT PROPERTIES | EXTRACT | Camellia sinensis - chemistry | Liver - pathology | Adipose Tissue, White - immunology | Obesity - immunology | Male | Obesity - blood | Anti-Obesity Agents - therapeutic use | Dietary Supplements - analysis | Liver - immunology | Polysaccharides - administration & dosage | Hypolipidemic Agents - chemistry | Polysaccharides - therapeutic use | Hypolipidemic Agents - analysis | Anti-Obesity Agents - administration & dosage | Specific Pathogen-Free Organisms | Anti-Inflammatory Agents, Non-Steroidal - analysis | Plant Extracts - isolation & purification | Random Allocation | Hyperlipidemias - prevention & control | Rats, Sprague-Dawley | Obesity - pathology | Anti-Obesity Agents - chemistry | Obesity - prevention & control | Polyphenols - analysis | Hypolipidemic Agents - therapeutic use | Polyphenols - therapeutic use | Plant Extracts - therapeutic use | Leptin - antagonists & inhibitors | Plant Extracts - chemistry | Caffeine - analysis | Caffeine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Anti-Obesity Agents - analysis | Plant Extracts - administration & dosage | Leptin - blood | Caffeine - therapeutic use | Polysaccharides - isolation & purification | Food Handling | Cytokines - blood | Plant Leaves - chemistry | Adipose Tissue, White - pathology | Polyphenols - isolation & purification | Polysaccharides - analysis | Caffeine - isolation & purification | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hyperlipidemias - etiology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Hypolipidemic Agents - administration & dosage | Cytokines - antagonists & inhibitors | Polyphenols - administration & dosage
Journal Article
Nature Reviews Drug Discovery, ISSN 1474-1776, 2014, Volume 13, Issue 6, pp. 433 - 444
The liver X receptors (LXRs) are pivotal regulators of lipid homeostasis in mammals. These transcription factors control the expression of a battery of genes... 
BINDING CASSETTE TRANSPORTER | BILIARY STEROL SECRETION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | REVERSE CHOLESTEROL TRANSPORT | ALZHEIMERS-DISEASE | LOW-DENSITY-LIPOPROTEIN | PROLIFERATOR-ACTIVATED RECEPTOR | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | EXPRESSION IN-VITRO | ATHEROSCLEROSIS SUSCEPTIBILITY | LXR-ALPHA | Intestines - drug effects | Drugs, Investigational - pharmacology | Humans | Drugs, Investigational - therapeutic use | Intestines - metabolism | Orphan Nuclear Receptors - metabolism | Brain - metabolism | Drugs, Investigational - chemistry | Protein Isoforms - metabolism | Liver - drug effects | Alzheimer Disease - prevention & control | Liver X Receptors | Drug Design | Neurons - metabolism | Hypolipidemic Agents - chemistry | Drug Evaluation, Preclinical | Neurons - drug effects | Hypolipidemic Agents - adverse effects | Nerve Tissue Proteins - antagonists & inhibitors | Molecular Targeted Therapy - adverse effects | Atherosclerosis - drug therapy | Liver - metabolism | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Clinical Trials as Topic | Hypolipidemic Agents - pharmacology | Nootropic Agents - adverse effects | Nootropic Agents - chemistry | Drug Discovery | Atherosclerosis - metabolism | Brain - drug effects | Nerve Tissue Proteins - metabolism | Orphan Nuclear Receptors - antagonists & inhibitors | Animals | Signal Transduction - drug effects | Alzheimer Disease - metabolism | Lipid Metabolism - drug effects | Hypolipidemic Agents - therapeutic use | Atherosclerosis - prevention & control | Nootropic Agents - pharmacology | Protein Isoforms - antagonists & inhibitors | Care and treatment | Research | Drug discovery | Patient outcomes | Risk factors | Atherosclerosis
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 04/2013, Volume 65, Issue 4, pp. 494 - 502
Objectives Simvastatin has recently been demonstrated to serve as a therapeutic agent for osteoporosis. However, it is hard to dissolve in water and has side... 
simvastatin | deoxycholic acid | micelles | osteoporosis | calcium phosphate | OSTEOCLAST | APATITE FORMATION | SIMULATED BODY-FLUID | PHARMACOLOGY & PHARMACY | STATINS | BONE-RESORPTION | Simvastatin - therapeutic use | Surface-Active Agents - adverse effects | Simvastatin - adverse effects | Humans | Deoxycholic Acid - chemistry | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Nanocapsules - adverse effects | Nanocapsules - chemistry | Bone and Bones - drug effects | Deoxycholic Acid - adverse effects | Micelles | Surface Properties | Calcium Phosphates - adverse effects | Drug Compounding | Female | Deoxycholic Acid - administration & dosage | Hypolipidemic Agents - chemistry | Bone Density Conservation Agents - chemistry | Disease Models, Animal | Cell Line | Hypolipidemic Agents - adverse effects | Bone Density Conservation Agents - adverse effects | Simvastatin - chemistry | Simvastatin - administration & dosage | Bone Density Conservation Agents - therapeutic use | Calcium Phosphates - chemistry | Deoxycholic Acid - therapeutic use | Bone Density Conservation Agents - administration & dosage | Random Allocation | Mice, Inbred Strains | Osteoporosis, Postmenopausal - drug therapy | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Hypolipidemic Agents - administration & dosage | Hypolipidemic Agents - therapeutic use | Mice | Surface-Active Agents - chemistry | Drug Delivery Systems - adverse effects | Osteoporosis | Calcium phosphate | Health aspects | Analysis | Simvastatin | Deoxycholic acid | Calcium | Medical treatment
Journal Article
Food and Function, ISSN 2042-6496, 3/2015, Volume 6, Issue 3, pp. 834 - 841
The present study investigated the anti-obesity and anti-diabetic effects of kaempferol glycoside (KG) fractions which were composed of four kaempferol... 
ENERGY-BALANCE | QUERCETIN | CELLS | OBESITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | GLUCOSIDES | KINASE | ALPHA | ABSORPTION | Glycated Hemoglobin A - analysis | Humans | Male | Anti-Obesity Agents - therapeutic use | Dietary Supplements - analysis | Soybeans - growth & development | Glycosides - isolation & purification | Kaempferols - isolation & purification | Diabetes Mellitus, Type 2 - etiology | Obesity - etiology | Hypolipidemic Agents - chemistry | Kaempferols - analysis | Glycosides - chemistry | Hypoglycemic Agents - therapeutic use | Hypolipidemic Agents - analysis | Kaempferols - chemistry | Obesity - complications | Diabetes Mellitus, Type 2 - prevention & control | Hypolipidemic Agents - isolation & purification | Lipid Metabolism | Plant Extracts - isolation & purification | Random Allocation | Hypoglycemic Agents - isolation & purification | Soybeans - chemistry | Anti-Obesity Agents - chemistry | Plant Leaves - growth & development | Obesity - prevention & control | Hypolipidemic Agents - therapeutic use | Plant Extracts - therapeutic use | Plant Extracts - chemistry | Hypoglycemic Agents - analysis | Diet, High-Fat - adverse effects | Anti-Obesity Agents - analysis | Kaempferols - therapeutic use | Diabetes Mellitus, Type 2 - metabolism | Adiposity | Diabetes Mellitus, Type 2 - complications | Plant Leaves - chemistry | Glycosides - analysis | Mice, Inbred C57BL | Insulin Resistance | Hypertriglyceridemia - metabolism | Hypoglycemic Agents - chemistry | Anti-Obesity Agents - isolation & purification | Obesity - metabolism | Hypertriglyceridemia - prevention & control | Animals | Hypertriglyceridemia - complications | Hypertriglyceridemia - etiology | Glycosides - therapeutic use
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 04/2013, Volume 65, Issue 4, pp. 591 - 603
Objectives This study was carried out to assess the anti‐obesity effect of Hypericum silenoides Juss. and Hypericum philonotis Cham. & Schlecht. in male Wistar... 
anti‐obesity natural products | tlanchalagua | cafeteria diet | Hypericum philonotis | Hypericum silenoides | anti-obesity natural products | Obesity - drug therapy | Rats, Wistar | Plant Extracts - pharmacology | Male | Obesity - blood | Anti-Obesity Agents - therapeutic use | Antidepressive Agents - isolation & purification | Depression - etiology | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Plant Extracts - administration & dosage | Hypoglycemic Agents - administration & dosage | Lipase - antagonists & inhibitors | Hypericum - growth & development | Antidepressive Agents - pharmacology | Plant Components, Aerial - growth & development | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Anti-Obesity Agents - administration & dosage | Plant Components, Aerial - chemistry | Enzyme Inhibitors - pharmacology | Hypolipidemic Agents - isolation & purification | Rats | Obesity - physiopathology | Plant Extracts - isolation & purification | Random Allocation | Hypolipidemic Agents - pharmacology | Enzyme Inhibitors - therapeutic use | Hyperlipidemias - prevention & control | Anti-Obesity Agents - isolation & purification | Enzyme Inhibitors - isolation & purification | Hypoglycemic Agents - pharmacology | Antidepressive Agents - therapeutic use | Hypoglycemic Agents - isolation & purification | Ethnopharmacology | Animals | Depression - prevention & control | Hyperlipidemias - etiology | Hypolipidemic Agents - administration & dosage | Antidepressive Agents - administration & dosage | Mexico | Hyperglycemia - etiology | Hypolipidemic Agents - therapeutic use | Medicine, Traditional | Anti-Obesity Agents - pharmacology | Plant Extracts - therapeutic use | Hypericum - chemistry
Journal Article